The Optoker company, which develops electronic glasses for the treatment of lazy eye and is one of the Ma'ayan technology incubator companies, recently received the approval of the US Food and Drug Administration to market its therapeutic product for lazy eye syndrome in children
The Ophtoker company has developed electronic glasses, based on innovative technology. The glasses will replace the inconvenient therapeutic method that exists today using a sticky bandage. These are glasses with optical lenses designed and adapted for children, which create by electronic means the darkness of the strong eye and consequently practice and strengthen the weak eye. The darkening is carried out with variable frequency and lengths of time while maintaining the child's comfort and allowing him to function normally and aesthetically in kindergarten, at school, with friends and at home.
Tzvika Ben Porat, CEO of Hamma Ma'ayan, said: "Getting FDA approval for marketing in the US is significant in the life of the company, which finished product development and conducted a series of successful medical trials during its activity in the greenhouse. Now we will assist the company in the additional round of fundraising in the amount of approximately 600 thousand dollars, intended for the expansion of production and marketing activities." Ben Porat noted that "in light of the product's market potential, which is protected by a patent, the company's forecasts are to reach a sales volume of more than 20 million dollars within 3 years with high profitability."
According to Rafi Herzog, CEO of Optoker, "the milestone of the FDA approval is a green light from our point of view for the marketing activity and the start of production in order to launch the product commercially within a few months, at the beginning of 2006".
Optoker started its activity in the Ma'ayan technology incubator about a year and a half ago and so far about NIS 2,000,000 has been invested in it. The company is now preparing for another recruitment round, in order to expand the production and marketing of the electronic glasses.
Ophtoker carried out the medical research for more than a year under the direction of Prof. David Ben Ezra from Hadassah Ein Kerem, Dr. Avraham Shapirer from Tel Hashomer Hospital and Dr. Yehudit Raz from the Meir Medical Center in Kfar Saba, which proved that the effectiveness of the treatment with glasses exceeds the effectiveness of the treatment through the traditional wetting. At the end of 9 months of treatment, it was found that more than 70% of the children improved their vision significantly. The feedback from the parents and the children showed that they prefer the new treatment method, it is convenient and reduces the frustration that accompanies the child and the parents in the usual treatment.
They knew innovations in medicine
One response
Interested in electronic glasses for a child